Abstract:Abstract Background Toxoplasma gondii is a foodborne parasite that induces monocyte recruitment and microglial activation during infection of the brain. Similarly, in Alzheimer’s disease (AD), activated immune cells are often found in the brain and these localize near amyloid beta plaques. However, after infection with T. gondii in AD mouse models, there are fewer amyloid beta plaques in the brain, increased microglial activation, and decreased severity of AD symptoms. We hypothesize that T. gondii infection activates and enhances the phagocytic ability of microglia to clear amyloid beta. Method Female 5xFAD mice were infected with T. gondii or PBS treated, and their brains harvested after 6 weeks of infection. Brain tissue from these animals was analyzed for amyloid (Amyloglo) and immune cell markers for microglia, monocytes, and T cells (IBA1, CD68, CD11c, CD11b, CD45, CD3) by light sheet imaging, confocal microscopy, or flow cytometry. Mice were also fitted with headplates and cranial windows and injected with methoxy‐X04 (10 mg/kg) to enable longitudinal imaging of amyloid over the span of infection. Result Confocal microscopy of brain sections and light sheet imaging of intact brains from infected and uninfected 5xFAD mice have shown increased microglial activation markers (IBA1 and CD68) and decreased amyloid surface area and volume throughout infected brains in infected animals. Infected mouse brains also have increased co‐localization of amyloid and CD68 compared to uninfected mouse brains. Two‐photon imaging reveals that amyloid plaque area in vivo no longer increases in infected mouse brains as early as three weeks post‐infection and lasts as long as thirteen weeks post‐infection. Additionally, after six weeks of infection, we see an increase in Disease Associate Microglia (DAM) by flow cytometry, as well as an influx of other immune cells in the brain of infected mice as compared to PBS treated control mice. Conclusion Our data show that infection with T. gondii increases microglial markers associated with the DAM profile and these cells likely increase phagocytosis of amyloid beta. Infection with T. gondii appears to modulate the neuroimmune environment, including responding microglial cells, resulting in a neuroprotective phenotype.

Type-1 diabetes mellitus down-regulated local cerebral glial fibrillary acidic protein expression in experimental toxoplasmosis

Expression of immunoproteasome subunits in the brains of Toxoplasma gondii-infected mice

Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients

Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by Toxoplasma gondii infection

Observing astrocyte polarization in brains from mouse chronically infected with Toxoplasma gondii

Behavior and neuropsychiatric changes in experimental chronic toxoplasmosis: Histopathological and immunohistochemical studies

Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles altering astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain

Toxoplasma gondii infection and its implications within the central nervous system

Toxoplasmosis of the central nervous system: Manifestations vary with immune responses

Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain

Toxoplasma gondii‐induced amyloid reduction and neuroimmune responses in Alzheimer’s disease

Could Metformin Modulate the Outcome of Chronic Murine Toxoplasmosis?

From Inflammatory Reactions to Neurotransmitter Changes: Implications for Understanding the Neurobehavioral Changes in Mice Chronically Infected with Toxoplasma Gondii.

Toxoplasma Gondii Induces Blood-Brain Barrier Dysfunction in a Human Stem Cell- Derived Model

Activation of Chronic Toxoplasmosis by Transportation Stress in a Mouse Model

Dimethyl Itaconate Ameliorates the Deficits of Goal-Directed Behavior in Toxoplasma Gondii Infected Mice.

Toxoplasma gondii infection accelerates the progression of hereditary spastic paraplegia

Contrasting Disease Progression, Microglia Reactivity, Tolerance, and Resistance to Toxoplasma gondii Infection in Two Mouse Strains

4D label-free proteomic analysis reveals key potential pathways of Toxoplasma invasion into the central nervous system

Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia

Toxoplasma Gondii Reactivation Aggravating Cardiac Function Impairment in Mice.